Ligand validation:7YYZ

VYT: Azo-Combretastatin A4 (trans)

VYT is a Ligand Of Interest in 7YYZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7YYZ_VYT_B_502	20%	95%	0.207	0.806	0.21	0.19	-	-	1	0	100%	1
8QL8_VYT_B_502	64%	58%	0.072	0.87	0.45	1.13	-	4	0	0	100%	1
8QL6_VYT_B_702	56%	47%	0.084	0.855	0.47	1.54	-	4	4	0	100%	1
8QLB_VYT_B_502	34%	60%	0.114	0.796	0.4	1.1	-	2	0	0	100%	1
8QL7_VYT_B_702	26%	47%	0.115	0.751	0.47	1.54	-	4	4	0	100%	1
7YYV_VYT_B_502	24%	63%	0.196	0.824	0.44	0.97	-	2	0	0	100%	1
7YYW_VYT_B_502	16%	57%	0.233	0.802	0.42	1.2	-	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.